The transcription factor E2F-1 is a downstream target of RB action

Molecular and Cellular Biology

Volumn 15, Issue 2, 1995, Pages 742-755

  Qin, Xiao Qiang ^a   Livingston, David M ^a   Ewen, Mark ^a   Sellers, William R ^a   Arany, Zoltan ^a   Kaelin Jr , William G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ADENOVIRUS; ARTICLE; CELL CYCLE G1 PHASE; DNA BINDING; DNA FLANKING REGION; DNA TRANSCRIPTION; GENE MUTATION; GENE REPRESSION; GROWTH DISORDER; HUMAN; HUMAN CELL; ONCOVIRINAE; PAPOVAVIRUS; PRIORITY JOURNAL; RETINOBLASTOMA; TRANSACTIVATION;

ADENOVIRIDAE; ONCOVIRINAE; PAPOVAVIRIDAE;

EID: 0028983370     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.15.2.742     Document Type: Article

References (99)

1. Bagchi, S., P. Raychaudhuri, and J. R. Nevins. 1990. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation. Cell 62:659-669.
2. Baker, S. J., S. Markowitz, E. Fearon, B. Willson, and B. Vogelstein. 1990. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912-915.
3. Bandara, L. R., V. M. Buck, M. Zamanian, L. H. Johnston, and N. B. La Thangue. 1993. Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. EMBO J. 12:4317-4324.
4. Bernards, R. Personal communication.
5. Blake, M., and J. C. Azizkhan. 1989. Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol. Cell. Biol. 9:4994-5002.
6. Bookstein, R., J. Shew, P. Chen, P. Scully, and W. Lee. 1990. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247:712-715.
7. Buchkovich, K., L. A. Duffy, and E. Harlow. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097-1105.
8. Chellapan, S., V. B. Kraus, B. Kroger, K. Munger, P. M. Howley, W. C. Phelps, and J. R. Nevins. 1992. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA 89:4549-4553.
9. Chen, P., P. Scully, J. Shew, J. Y. Wang, and W. Lee. 1989. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58:1193-1198.
10. Chittenden, T., D. M. Livingston, and J. A. DeCaprio. 1993. Cell cycle analysis of E2F in primary human T cells reveals novel E2F complexes and biochemically distinct forms of "free" E2F. Mol. Cell. Biol. 13:3975-3983.
11. Cress, W. D., D. G. Johnson, and J. R. Nevins. 1993. A genetic analysis of the E2F-1 gene distinguishes regulation by Rb, p107, and adenovirus E4. Mol. Cell. Biol. 13:6314-6325.
12. Dalton, S. 1992. Cell cycle regulation of the human cdc2 gene. EMBO J. 11:1797-1804.
13. DeCaprio, J. A., Y. Furukawa, F. Ajchenbaum, J. Griffen, and D. M. Livingston. 1992. The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc. Natl. Acad. Sci. USA 89:1795-1798.
14. DeCaprio, J., and W. Kaelin. Unpublished data.
15. DeCaprio, J. A., J. W. Ludlow, D. Lynch, Y. Furukawa, J. Griffin, H. Piwnica-Worms, C.-M. Huang, and D. M. Livingston. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085-1095.
16. Defeo-Jones, D., P. S. Huang, R. E. Jones, K. M. Haskell, G. A. Vuuocolo, M. G. Hanobik, H. E. Huber, and A. Oliff. 1991. Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature (London) 352:251-254.
17. Dowdy, S. F., P. W. Hinds, K. Louie, S. I. Reed, A. Arnold, and R. A. Weinberg. 1993. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73:499-511.
18. Dyson, N., M. Dembski, A. Fattaey, C. Ngwu, M. Ewen, and K. Helin. 1993. Analysis of p107-associated protein: p107 associates with a form of E2F that differs from pRB-associated E2F-1. J. Virol. 67:7641-7647.
19. Ewen, M. E., H. K. Sluss, C. J. Sherr, H. Matsushime, J.-Y. Kato, and D. M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497.
20. Ewen, M. E., H. K. Sluss, L. L. Whitehouse, and D. M. Livingston. 1993. TGFb inhibition of Cdk4 synthesis is linked to cell cycle arrest. Cell 74:1009-1020.
21. Fattaey, A. R., K. Helin, M. S. Dembski, N. Dyson, E. Harlow, G. A. Vuocolo, M. G. Hanobik, K. M. Haskell, A. Oliff, D. Defeo-Jones, and R. E. Jones. 1993. Characterization of the retinoblastoma binding proteins RBP1 and RBP2. Oncogene 8:3149-3156.
22. Field, S., M. Greenberg, and W. G. Kaelin, Jr. Unpublished data.
23. Flemington, E. K., S. H. Speck, and W. G. Kaelin. 1993. E2F-1 mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 90:6914-6918.
24. Ginsberg, D., T. Chittenden, G. Vairo, and D. M. Livingston. Unpublished data.
25. Girling, R., J. F. Partridge, L. R. Bandara, N. Burden, N. F. Totty, J. J. Hsuan, and N. B. La Thangue. 1993. A new component of the transcription factor DRTF1/E2F 1. Nature (London) 362:83-87.
26. Goldstein, S. Personal communication.
27. Goodrich, D. W., and W.-H. Lee. 1992. Abrogation by c-myc of G1 phase arrest induced RB protein but not by p53. Nature (London) 360:177-179.
28. Goodrich, D. W., N. P. Wang, Y.-W. Qian, E. Y. Lee, and W.-H. Lee. 1991. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67:293-302.
29. Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547-5551.
30. Gu, W., J. W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal-Ginard. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309-324.
31. Hagemeier, C., A. J. Bannister, A. Cook, and T. Kouzarides. 1993. The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc. Natl. Acad. Sci. USA 90:1580-1584.
32. Hamel, P. A., R. M. Gill, R. A. Phillips, and B. L. Gallie. 1992. Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol. Cell. Biol. 12:3431-3438.
33. Hamel, P. A., R. M. Gill, R. A. Phillips, and B. L. Gallie. 1992. Regions controlling hyperphosphorylation and conformation of the retinoblastoma gene product are independent of domains required for transcriptional repression. Oncogene 7:693-701.
34. Helin, K., and E. Harlow. 1994. Heterodimerization of the transcription factors E2F1 and DP1 is required for binding to the adenovirus E4 (ORF 6/7) protein. J. Virol. 68:5027-5035.
35. Helin, K., E. Harlow, and A. Fattaey. 1993. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13: 6501-6507.
36. Helin, K., J. A. Lees, M. Vidal, N. Dyson, E. Harlow, and A. Fattaey. 1992. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70:337-350.
37. Helin, K., C.-L. Wu, A. R. Fattaey, J. A. Lees, B. D. Dynlacht, C. Ngwu, and E. Harlow. 1993. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative transactivation. Genes Dev. 7:1850-1861.
38. Hiebert, S. W. 1993. Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol. Cell. Biol. 13:3384-3391.
39. Hiebert, S. W., M. Blake, J. Azizkhan, and J. R. Nevins. 1991. Role of E2F transcription factor in E1A-mediated trans activation of cellular genes. J. Virol. 65:3547-3552.
40. Hiebert, S. W., S. P. Chellappan, J. M. Horowitz, and J. R. Nevins. 1992. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 6:177-185.
41. Hinds, P. W., S. Mittnacht, V. Dulic, A. Arnold, S. I. Reed, and R. A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006.
42. Horowitz, J. M., S. Park, E. Bogenmann, J. Cheng, D. W. Yandell, F. J. Kaye, J. D. Minna, T. P. Dryja, and R. A. Weinberg. 1990. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc. Natl. Acad. Sci. USA 87:2775-2779.
43. Horowitz, J. M., D. W. Yandell, S. Park, S. Canning, P. Whyte, K. Buchkovich, E. Harlow, R. A. Weinberg, and T. P. Dryja. 1989. Point mutational inactivation of the retinoblastoma antioncogene. Science 243:937-940.
44. Hu, Q., N. Dyson, and E. Harlow. 1990. The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J. 9:1147-1155.
45. Huang, H.-J. S., J.-K. Yee, J.-Y. Shew, P.-L. Chen, R. Bookstein, T. Friedmann, E. Y.-H. Lee, and W.-H. Lee. 1988. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242:1563-1566.
46. Huang, P. S., D. R. Patrick, G. Edwards, P. J. Goodhart, H. E. Huber, L. Miles, V. M. Garsky, A. Oliff, and D. C. Heimbrook. 1993. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Mol. Cell. Biol. 13:953-960.
47. Huang, S., W.-H. Lee, and E. Y.-H. Lee. 1991. A cellular protein that competes with SV40 T antigen for binding the retinoblastoma gene product. Nature (London) 350:160-162.
48. Huang, S., N. Wang, B. Y. Tseng, W.-H. Lee, and E. H. Lee. 1990. Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen. EMBO J. 9:1815-1822.
49. Huber, H. E., G. Edwards, P. J. Goodhart, D. R. Patrick, P. S. Huang, M. Ivey-Hoyle, S. F. Barnett, A. Oliff, and D. C. Heimbrook. 1993. Transcription factor E2F binds DNA as a heterodimer. Proc. Natl. Acad. Sci. USA 90: 3525-3529.
50. Ivey-Hoyle, M., R. Conroy, H. E. Huber, P. J. Goodhart, A. Oliff, and D. C. Heimbrook. 1993. Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol. Cell. Biol. 13:7802-7812.
51. Johnson, D. G., K. Ohtani, and J. R. Nevins. 1994. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev. 8:1514-1525.
52. Johnson, D. G., J. K. Schwarz, W. D. Cress, and J. R. Nevins. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature (London) 365:349-352.
53. Kaelin, W. G., M. E. Ewen, and D. M. Livingston. 1990. Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product. Mol. Cell. Biol. 10:3761-3769.
54. Kaelin, W. G., W. Krek, W. R. Sellers, J. A. DeCaprio, F. Ajchenbaum, C. S. Fuchs, T. Chittenden, Y. Li, P. J. Farnham, M. A. Blanar, D. M. Livingston, and E. K. Flemington. 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70:351-364.
55. Kaelin, W. G., D. C. Pallas, J. A. DeCaprio, F. J. Kaye, and D. M. Livingston. 1991. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell 64:521-532.
56. Kato, J.-Y., H. Matsushime, S. W. Hiebert, M. E. Ewen, and C. J. Sherr. 1993. Direct binding of cyclin D to the retinoblastoma gene product and pRB phosphorylation by the cyclin D-dependent kinase, cdk4. Genes Dev. 7:331-342.
57. Kaye, F. J., R. A. Kratzke, J. L. Gerster, and J. M. Horowitz. 1990. A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc. Natl. Acad. Sci. USA 87: 6922-6926.
58. Kern, S. E., K. W. Kinzler, A. Bruskin, D. Jarosz, P. Freidman, C. Prives, and B. Vogelstein. 1991. Identification of p53 as a sequence specific DNA-binding protein. Science 252:1708-1711.
59. Kim, S.-J., U. S. Onwuta, Y. I. Lee, R. Li, M. R. Botchan, and P. D. Robbins. 1992. The retinoblastoma gene product regulates Sp-1-mediated transcription. Mol. Cell. Biol. 12:2455-2463.
60. Krek, W., M. Ewen, S. Shirodkar, Z. Arany, W. G. Kaelin, and D. M. Livingston. 1994. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78:1-20.
61. Krek, W., D. M. Livingston, and S. Shirodkar. 1993. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 262:1557-1560.
62. Laiho, M., J. A. DeCaprio, J. W. Ludlow, D. M. Livingston, and J. Massagué. 1990. Growth inhibition by TGF-b linked to suppression of retinoblastoma protein phosphorylation. Cell 62:175-185.
63. Lam, E. W.-F., and R. J. Watson. 1993. An E2F-binding site mediates cell-cycle regulated repression of mouse B-Myb transcription. EMBO J. 12:2705-2713.
64. Lees, J. A., M. Saito, M. Vidal, M. Valentine, T. Look, E. Harlow, N. Dyson, and K. Helin. 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13:7813-7825.
65. Ludlow, J. W., J. A. DeCaprio, C. Huang, W. Lee, E. Paucha, and D. M. Livingston. 1989. SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 56:57-65.
66. Ludlow, J. W., C. L. Glendening, D. M. Livingston, and J. A. DeCaprio. 1993. Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol. Cell. Biol. 13:367-372.
67. Ludlow, J. W., J. Shon, J. M. Pipas, D. M. Livingston, and J. A. DeCaprio. 1990. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell 60:387-396.
68. Means, A. L., J. E. Slansky, S. L. McMahon, M. W. Knuth, and P. J. Farnham. 1992. The HIP1 binding site is required for growth regulation of the dihydrofolate reductase gene promoter. Mol. Cell. Biol. 12:1054-1063.
69. Mihara, K., X. Cao, A. Yen, S. Chandler, B. Driscoll, A. L. Murphree, A. T'Ang, and Y. Fung. 1989. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 246:1300-1303.
70. Mittnacht, S., and R. A. Weinberg. 1991. G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell 65:381-393.
71. Moberg, K. H., T. J. Logan, and D. J. Tyndall. 1992. Three distinct elements within the murine c-myc promoter are required for transcription. Oncogene 7:411-421.
72. Mudryj, M., S. H. Devoto, S. W. Hiebert, T. Hunter, J. Pines, and J. R. Nevins. 1991. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell 65:1243-1253.
73. Mudryj, M., S. W. Hiebert, and J. R. Nevins. 1990. A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. EMBO J. 9:2179-2184.
74. Neuman, E., E. K. Flemington, W. R. Sellers, and W. G. Kaelin, Jr. 1994. Transcription of the E2F1 gene is rendered cell-cycle dependent by E2F DNA-binding sites within its promoter. Mol. Cell. Biol. 14:6607-6615.
75. Nevins, J. R. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429.
76. Pearson, B. E., H. P. Nasheuer, and T. S. F. Wang. 1991. Human DNA polymerase α gene, sequences controlling expression in cycling and serum-stimulated cells. Mol. Cell. Biol. 11:2081-2095.
77. Qian, Y., C. Luckey, L. Horton, M. Esser, and D. J. Templeton. 1992. Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding. Mol. Cell. Biol. 12:5363-5372.
78. Qin, X.-Q., T. Chittenden, D. M. Livingston, and W. G. Kaelin. 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6:953-964.
79. Qin, X.-Q., D. M. Livingston, and W. G. Kaelin. Unpublished data.
80. Qin, X. Q., D. M. Livingston, W. G. Kaelin, and P. Adams. 1994. Deregulated E2F1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91:10918-10922.
81. Raychaudhuri, P., S. Bagchi, S. H. Devoto, V. B. Krauss, E. Moran, and J. R. Nevins. 1991. Domains of the adenovirus E1A protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes. Genes Dev. 5:1200-1211.
82. Rustgi, A. K., N. Dyson, and R. Bernards. 1991. Amino-terminal domains of c-myc and n-myc proteins mediate binding to the retinoblastoma gene product. Nature (London) 352:541-544.
83. Scheffner, M., K. Munger, J. C. Byrne, and P. M. Howley. 1991. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA 88:5523-5527.
84. Schwarz, J. K., S. H. Devoto, E. J. Smith, S. P. Chellappan, L. Jakoi, and J. R. Nevins. 1993. Interactions of the p107 and Rb proteins with E2F during the cell proliferation response. EMBO J. 12:1013-1020.
85. Shan, B., X. Zhu, P.-L. Chen, T. Durfee, Y. Yang, D. Sharp, and W.-H. Lee. 1992. Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol. Cell. Biol. 12:5620-5631.
86. Shew, J., P. Chen, R. Bookstein, E. Y. Lee, and W. Lee. 1990. Deletion of a splice donor site ablates expression of the following exon and produces an unphosphorylaled RB protein unable to bind SV40 T antigen. Cell Growth Differ. 1:17-25.
87. Shirodkar, S., M. Ewen, J. A. DeCaprio, J. Morgan, D. M. Livingston, and T. Chittenden. 1992. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68:157-166.
88. Shirodkar, S., and D. M. Livingston. Unpublished data.
89. Slansky, J. E., Y. Li, W. G. Kaelin, and P. J. Farnham. 1993. A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the DHFR promoter. Mol. Cell. Biol. 13:1610-1618.
90. Takahashi, R., T. Hashimoto, H.-J. Xu, S.-X. Hu, T. Maatsui, T. Miki, H. Bigo-Marshall, S. A. Aaronson, and W. F. Benedict. 1991. The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proc. Natl. Acad. Sci. USA 88:5257-5261.
91. Tedder, T., and C. M. Isaacs. 1989. Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. J. Immunol. 143:712-717.
92. Templeton, D. J., S. H. Park, L. Lanier, and R. Weinberg. 1991. Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc. Natl. Acad. Sci. USA 88:3033-3037.
93. Thalmeier, K., H. Synovzik, R. Mertz, E.-L. Winnacker, and M. Lipp. 1989. Nuclear factor E2F mediates basic transcription and trans-activation by E1A of the human MYC promoter. Genes Dev. 3:527-538.
94. Wang, C.-Y., B. Petryniak, C. B. Thompson, W. G. Kaelin, and J. M. Leiden. 1993. Regulation of an ETS-related transcription factor, Elf-1 binding to the retinoblastoma protein. Science 260:1330-1335.
95. Weintraub, S. J., C. A. Prater, and D. C. Dean. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature (London) 358:259-261.
96. Welch, P. J., and J. Y. J. Wang. 1993. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75:779-790.
97. Wu, X., and A. J. Levine. 1994. p53 and E2F1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91:3602-3606.
98. Zamanian, M., and N. B. La Thangue. 1993. Transcriptional repression by the RB-related protein p107. Mol. Biol. Cell 4:389-396.
99. Zhu, L., S. van den Heuvel, K. Helin, A. Fattaey, M. E. Ewen, D. M. Livingston, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7:1111-1125.